Uniphar (DUB:UPR) Payments of Debt: €-175 Mil (TTM As of Dec. 2025)


DUB:UPR Uniphar PLC DUB:UPR
81 GF Score
Price €4.82
GF Value €3.64
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Uniphar Payments of Debt?

Uniphar DUB:UPR +0.42% 81 Payments of Debt is €-175 Mil as of Dec. 2025. GuruFocus rates DUB:UPR with a GF Score™ of 81/100 and a GF Value™ of €3.64 (Significantly Overvalued). The stock has 9 warning signs investors should review.

Uniphar's Payments of Debt for the six months ended in Dec. 2025 was €-173 Mil.

Uniphar's Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2025 was €-175 Mil.

Uniphar Payments of Debt Related Terms

Uniphar Payments of Debt Historical Data

* Premium members only.

The historical data trend for Uniphar's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Uniphar Payments of Debt Chart

Uniphar Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -13.95 -29.58 -1.60 -37.52 -175.32

Uniphar Semi-Annual Data
Dec16 Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.17 -12.56 -24.96 -2.07 -173.24
DUB:UPR
81GF Score
Uniphar PLC DUB:UPR
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Uniphar Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-175 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of €-175 Mil mean?
Uniphar (DUB:UPR) has a Payments of Debt of €-175 Mil as of Dec. 2025. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Uniphar and its competitors.
Is Uniphar's Payments of Debt too high?
Uniphar's current Payments of Debt is €-175 Mil. Overall, Uniphar has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Uniphar's Payments of Debt compare to MCK and CAH?
Uniphar's Payments of Debt of €-175 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Medical Distribution company?
A good Payments of Debt depends on the Medical Distribution industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Uniphar and its competitors. Uniphar's current Payments of Debt is €-175 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uniphar stock overvalued right now?
Based on GuruFocus' analysis, Uniphar (DUB:UPR) is currently considered Significantly Overvalued. The stock's GF Value™ is €3.64, compared to a current price of €4.82 — trading 32.4% above its estimated fair value. The current Payments of Debt is €-175 Mil. Uniphar's overall GF Score™ is 81/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Uniphar (DUB:UPR), the current Payments of Debt is €-175 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Uniphar (DUB:UPR) Overvalued in 2026?

Based on GuruFocus' analysis, Uniphar stock appears to be overvalued. The current stock price of €4.82 is trading 32.4% above its estimated GF Value™ of €3.64. GuruFocus considers Uniphar to be Significantly Overvalued.

Key valuation signals for DUB:UPR:

  • Payments of Debt: €-175 Mil
  • GF Value™: €3.64 vs. price of €4.82 (32.4% above fair value)
  • GF Score™: 81/100 with 9 warning signs

No single metric tells the full story. See the DUB:UPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Uniphar Business Description

Other Exchanges UPR:UK0NR:Germany
Address 4045 Kingswood Road, Citywest Business Park, Dublin, IRL, D24 V06K
Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies.
81GF Score

Get the complete analysis for DUB:UPR

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.82
Price
€3.64
GF Value